Philipp Gild retweeted
Congrats to @mwvetterlein on a brilliant MANTA bulbar urethroplasty at IMORU XI! 3 days of top-notch live reconstructive surgeries here in Hamburg. Truly a world-class meeting. @UKEHamburg #Urology #LiveSurgery #Urethroplasty
Philipp Gild retweeted
Excited to share our latest work on female non-obstetric urogenital fistula repair! We dive into long-term patient-reported outcomes and provide a comprehensive review. Proud to collaborate with @mwvetterlein @DrShariat @UKEHamburg on this important work. R. Dahlem, M. Fisch.
Female non-obstetric urogenital fistula repair: long-term patient-reported outcomes and a scoping literature review
@JakobFelin @mwvetterlein
doi.org/10.1111/bju.16395
Philipp Gild retweeted
Excellent plenary panel on the challenging to manage radiation induced posterior stenosis by @ajskokan @boyd_viersMD @MFrancescaMD @mwvetterlein. Challenging to manage patients requiring reconstructive experts! #AUA2024
Philipp Gild retweeted
Looking forward to a fantastic meeting with high-profile international faculty for live/semi-live surgery, meet-the-expert & poster sessions, state-of-the-art talks on the full spectrum of reconstructive urology. We’re excited to see you in Hamburg next year ⚓️⛴️👨⚕️👩⚕️Stay tuned.
Excited to announce a #SavetheDate for #IMORU25 in Hamburg, Germany @UKEHamburg. March 26-28, 2025. Navigating the Future of Reconstructive Urology. Stay tuned for further updates soon. imoru.de
Philipp Gild retweeted
Excited to announce a #SavetheDate for #IMORU25 in Hamburg, Germany @UKEHamburg. March 26-28, 2025. Navigating the Future of Reconstructive Urology. Stay tuned for further updates soon. imoru.de – at Hamburg, Germany
Philipp Gild retweeted
We need procedure-specific comorbidity assessments, as standard comorbidity indices are too generic to predict postop. morbidity! Check out our latest paper authors.elsevier.com/a/1iOuo…
@mwvetterlein @DrShariat @MichaelRink_MD @JakobFelin @M_Koelker @VMS78880496 @FredKoenig @PAEGild
Philipp Gild retweeted
Delighted to share our new publication on antithrombotic therapy among bladder cancer patients undergoing radical cystectomy
authors.elsevier.com/a/1hzUS…
@ejsotweets @JakobFelin @mvdeimling @PAEGild, Roland Dahlem, Margit Fisch @MichaelRink_MD @mwvetterlein @UKEHamburg
Philipp Gild retweeted
Delighted to finally share our MANTA urethroplasty, a ventral approach for short obliterative segments in longer bulbar strictures doi.org/10.1111/bju.16112 @BJUIjournal Phillip Marks @JakobFelin @FredKoenig @DingLiucheng, Florian Janisch @UKEHamburg – at Eppendorf, Hamburg
Philipp Gild retweeted
Thrilled to announce the publication of our in-depth Time-to-Complication Following Radical Cystectomy Analysis in @EurUrolFocus. sciencedirect.com/science/ar…
#urology #research @DrShariat @mvdeimling @M_Koelker @mwvetterlein @PAEGild
Philipp Gild retweeted
#EAU23 It‘s a wrap! 15 talks, 15 expert interviews, 2 board meetings, 1 guideline panel meeting, 1 chair @UKEHamburg #Urology Off to new endeavors! CU in #Paris #EAU24 @M_Koelker @FredKoenig @JakobFelin @DkFilipas @mvdeimling Florian Janisch @Uroweb @eau_yuo – at Milano, Lombardia
Philipp Gild retweeted
Rethink the #complementsystem in nephrology and enjoy beautiful Hamburg! Join the Freiwald lab at the University Center Hamburg-Eppendorf @HCKH_Hamburg @UKEHamburg. BMBF-funded positions for PhD, Post-doc and Technician. Get in touch at freiwaldlab.com.
Philipp Gild retweeted
Should I step down as head of Twitter? I will abide by the results of this poll.
57%Yes
43%No
17,502,391 votes • Final results Philipp Gild retweeted
#VulvarCancer in a trans man - rare, easily overlooked, but devastating diagnosis. Have a look at our @BJUIjournal case of the month from @UKEHamburg @VMS78880496 @ArminSoave @MichaelRink_MD @EAU_YAURecon @Uroweb @EAUYAUrology
bjui-journals.onlinelibrary.…
Philipp Gild retweeted
Partial-nephrectomy should not be categorically withheld from patients with high complexity renal masses.
🚨Take a look at our new study fresh off the press🚨: authors.elsevier.com/a/1fy-H…
@xianmeyer
@MichaelRink_MD
@PAEGild
@mwvetterlein
@UrolOncol @Uroweb
Philipp Gild retweeted
Check out our recent validation of #PROMETRICS @atiqullah_aziz pentafecta criteria after open radical cystectomy: valuable tool, but needs refinement. Great work @mvdeimling @PAEGild @MichaelRink_MD @M_Koelker @JakobFelin @FredKoenig @UKEHamburg bjui-journals.onlinelibrary.…
Philipp Gild retweeted
Replying to @PAEGild
Philipp Gild retweeted
The 2022 #AQuilon team and alumni dinner at #AUA22 #NOLA
Our strength lies in our #Diversity and 🌍 representation
🇺🇸 🇬🇧 🇩🇪 🇻🇳 🇮🇹 🇷🇴 🇮🇳 🇨🇦 🇱🇧 🇸🇦 🇮🇶 🇨🇳 🇫🇷 🇧🇷 🇲🇽 🇹🇼 🇸🇬 🇵🇰 🇰🇷 – at New Orleans, LA
Philipp Gild retweeted
Spannende uro-onkologische Fortbildung am 6./7. August in HH. Präsenz und Virtuell möglich. Anmeldung über QR Code. @amerseburger @wulfingc @mwvetterlein @PAEGild @miokra
Philipp Gild retweeted
Out now: our new paper on copy number variations in various oncogenes and tumor suppressor genes in primary tumor tissue, lymph node metastasis and cfDNA of bladder cancer patients treated with radical cystectomy.
Philipp Gild retweeted
Our new paper on impact of CTC on VTE risk in bladder cancer is out! CTC no qualified biomarker for more tailored thromboprophylaxis management @mwvetterlein @PAEGild @MichaelRink_MD @AS03202493 @BenjaminPradere @evanguelosx @amerseburger
Welcome to read "The Impact of Circulating Tumor Cells on Venous Thromboembolism and Cardiovascular Events in Bladder Cancer Patients Treated with Radical Cystectomy", by Michael Rink, et al.
mdpi.com/2077-0383/9/11/3478
#bladder
#cancer































